Promega announces the launch of GenePrint®10 System for human cell line authentication and sample identification. GenePrint 10 includes the eight loci recommended by the ANSI Standard (ASN-0002) Authentication of Human Cell Lines: Standardization of STR Profiling1, plus Amelogenin for gender identification and the highly polymorphic D21S11 locus for additional power of discrimination. Short Tandem Repeat (STR) analysis begins with amplification, and the GenePrint10 System contains all materials necessary to co-amplify human STR loci, using a hot-start thermostable DNA polymerase and a robust buffer compatible with fast cycling and direct amplification from substrates.

Tissue culture cells, important tools in many laboratories, are often misidentified or contaminated with other cells, wasting substantial time, effort and laboratory resources and potentially invalidating published data. To remedy this issue, the National Institute of Health and many journals now recommend or require cell line authentication before grant approval or acceptance for publication, making cell line authentication a very important concern for researchers.

Cell line authentication using the GenePrint 10 System allows researchers to spend less time worrying about the authenticity of their cells and more time advancing their research. For more information, visit the Promega web site at: https://www.promega.com/geneprint10.

About Promega

Promega Corporation has provided products for DNA-based human identification for over 20 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.